In a recent development, The Coca-Cola Company has voluntarily recalled 241 cases of its Topo Chico Mineral Water (16.9 fl oz bottles) due to potential contamination with Pseudomonas bacteria, according to an announcement made by the U.S. Food and Drug Administration (FDA). The recall has been classified as Class II, signaling a moderate health risk.
The recall was initiated following concerns that Pseudomonas aeruginosa, a bacterium that poses infection risks, particularly to vulnerable populations, might be present in select batches. The issue came to light when a distributor accidentally released products that were under a quality hold.
About Pseudomonas:
The Centers for Disease Control and Prevention (CDC) explains that Pseudomonas aeruginosa is commonly found in soil and water. While generally not harmful to healthy individuals, it can lead to infections in hospitalized or immunocompromised individuals, especially those with catheters, open wounds, or on ventilators.
The affected Topo Chico Mineral Water (Carbonated) bottles are:
Bottle UPC: 0 21136 18061 9
Case UPC: 0 21136 18062 6
Lot Numbers:
11 A 2543
12 A 2543
13 A 2541
Packaging Size: 16.9 fl oz (500 ml) bottles
Manufacturer: CIA. TOPO CHICO, S. DE R.L. DE C.V., Monterrey, Mexico
States Shipped To: Arizona, Louisiana, New Mexico, Nevada, and Texas
The affected bottles were distributed across approximately 40 retail locations in five U.S. states. Coca-Cola responded swiftly, notifying the FDA, initiating a voluntary recall on May 28, 2025, and confirming that all impacted products have now been removed from store shelves.
A spokesperson stated:
“We proactively notified the U.S. FDA of the potential contamination and initiated a voluntary recall. There have been no reported illnesses, and the issue has been contained.”
Consumers who have purchased Topo Chico Mineral Water from the affected regions are advised to:
Check the UPC and lot numbers carefully
Stop using the product immediately if it matches the recall details
Contact Coca-Cola or return the product to the place of purchase for a refund or replacement
While the health risk is considered moderate, immunocompromised individuals are urged to exercise extra caution.
The FDA classifies a Class II recall as one in which exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse consequences is remote.
Source: Newsweek